Marine Drugs · 2015 · 41 citations · 23 references
Life SciencesMarine BiologyMicrobiologyCancer PharmacologyDrug DiscoveryMicrobial EcologyBioactive Small MoleculesFungal Secondary MetabolitesMarine Bioactive CompoundsMarine Natural Product BiosynthesisMetabolite IdentificationAbsolute Configuration AssignmentBioactive Compounds From Marine FungiBioactive Marine MetabolitesMarine Fungal MetabolitesMarine Microbial Secondary MetabolitesMarine Secondary MetabolitesMetabolite IsolationSecondary Metabolites
A screening of our actinomycete fraction library against the NCI-60 SKOV3 human tumor cell line led to the isolation of isopimara-2-one-3-ol-8,15-diene (1), lagumycin B (2), dehydrorabelomycin (3), phenanthroviridone (4), and WS-5995 A (5). These secondary metabolites were produced by a Micromonospora sp. isolated from sediment collected off the Cát Bà peninsula in the East Sea of Vietnam. Compound 1 is a novel Δ(8,9)-pimarane diterpene, representing one of approximately 20 actinomycete-produced diterpenes reported to date, while compound 2 is an angucycline antibiotic that has yet to receive formal characterization. The structures of 1 and 2 were elucidated by combined NMR and MS analysis and the absolute configuration of 1 was assigned by analysis of NOESY NMR and CD spectroscopic data. Compounds 2-5 exhibited varying degrees of cytotoxicity against a panel of cancerous and non-cancerous cell lines. Overall, this study highlights our collaborative efforts to discover novel biologically active molecules from the large, underexplored, and biodiversity-rich waters of Vietnam's East Sea.
23
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke, Rileen Sinha, Douglas A. Levine et al. · Nature Communications · 2013 · 1.5K citations · Full text